Biomedical Engineering Reference
In-Depth Information
at topoisomerase I on chromosome 20.
Eur J Cancer
, 1993.
29A
(10):
1469-1475.
120. Murphy, D.S.,
, Interphase cytogenetic analysis of erbB2 and topoII
alpha co-amplification in invasive breast cancer and polysomy of
chromosome 17 in ductal carcinoma
et al.
in situ
.
Int J Cancer
, 1995.
64
(1):
18-26.
121. Smith, K.,
, Topoisomerase II alpha co-amplification with erbB2 in
human primary breast cancer and breast cancer cell lines: relationship
to m-AMSA and mitoxantrone sensitivity.
et al.
Oncogene
, 1993.
8
(4): 933-
938.
122. Tomasetto, C.,
, Identification of four novel human genes amplified
and overexpressed in breast carcinoma and localized to the q11-q21.3
region of chromosome 17.
et al.
Genomics
, 1995.
28
(3): 367-376.
123. van de Vijver, M.,
, Amplification of the neu (c-erbB-2) oncogene
in human mammmary tumors is relatively frequent and is often
accompanied by amplification of the linked c-erbA oncogene.
et al.
Mol Cell
Biol
, 1987.
7
(5): 2019-2023.
124. Press, M.F.,
, Alteration of topoisomerase II-alpha gene in human
breast cancer: association with responsiveness to anthracycline-based
chemotherapy.
et al.
J Clin Oncol
, 2011.
29
(7): 859-867.
125. Knoop, A.S.,
, retrospective analysis of topoisomerase IIa
amplifications and deletions as predictive markers in primary
breast cancer patients randomly assigned to cyclophosphamide,
methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and
fluorouracil: Danish Breast Cancer Cooperative Group.
et al.
J Clin Oncol
,
(30): 7483-7490.
126. O'Malley, F.P.,
2005.
23
, Topoisomerase II alpha and responsiveness of
breast cancer to adjuvant chemotherapy.
et al.
J Natl Cancer Inst
, 2009.
(9): 644-650.
127. Gudkov, A.V.,
101
, Isolation of genetic suppressor elements, inducing
resistance to topoisomerase II-interactive cytotoxic drugs, from
human topoisomerase II cDNA.
et al.
Proc Natl Acad Sci U S A
, 1993.
90
(8):
3231-3235.
128. Withoff, S.,
, Selection of a subpopulation with fewer DNA
topoisomerase II alpha gene copies in a doxorubicin-resistant cell line
panel.
et al.
Br J Cancer
, 1996.
74
(4): 502-507.
129. Zhou, Z.,
, Adenovirus-mediated human topoisomerase IIalpha
gene transfer increases the sensitivity of etoposide-resistant human
breast cancer cells.
et al.
Cancer Res
, 1999.
59
(18): 4618-4624.
